Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Phreesia Inc (PHR)

Phreesia Inc (PHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,216,837
  • Shares Outstanding, K 57,398
  • Annual Sales, $ 356,300 K
  • Annual Income, $ -136,890 K
  • 60-Month Beta 0.92
  • Price/Sales 3.41
  • Price/Cash Flow N/A
  • Price/Book 4.81
Trade PHR with:

Options Overview Details

View History
  • Implied Volatility 47.85% ( +2.58%)
  • Historical Volatility 49.24%
  • IV Percentile 14%
  • IV Rank 8.89%
  • IV High 109.25% on 12/05/23
  • IV Low 41.85% on 06/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 27
  • Volume Avg (30-Day) 236
  • Put/Call OI Ratio 2.63
  • Today's Open Interest 9,067
  • Open Int (30-Day) 10,355

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 07/31/24
See More
  • Average Estimate -0.37
  • Number of Estimates 5
  • High Estimate -0.33
  • Low Estimate -0.43
  • Prior Year -0.68
  • Growth Rate Est. (year over year) +45.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.26 +13.96%
on 06/03/24
22.00 -5.41%
on 06/28/24
+1.89 (+9.99%)
since 05/31/24
3-Month
17.73 +17.39%
on 05/31/24
24.40 -14.71%
on 05/17/24
-2.27 (-9.84%)
since 04/01/24
52-Week
12.05 +72.70%
on 10/30/23
34.98 -40.51%
on 07/12/23
-10.20 (-32.89%)
since 06/30/23

Most Recent Stories

More News
Phreesia: Fiscal Q1 Earnings Snapshot

Phreesia: Fiscal Q1 Earnings Snapshot

PHR : 20.73 (-2.22%)
Phreesia: Fiscal Q4 Earnings Snapshot

Phreesia: Fiscal Q4 Earnings Snapshot

PHR : 20.73 (-2.22%)
Phreesia: Fiscal Q3 Earnings Snapshot

Phreesia: Fiscal Q3 Earnings Snapshot

PHR : 20.73 (-2.22%)
Buy the Dip: These 2 Stocks Have Traded Lower for 5 Consecutive Days

On the hunt for bargains, I’ve found a couple of stocks to buy whose shares are at or near their bottom. Of course, to buy them, you’ll probably need more than a little liquid courage.

PHR : 20.73 (-2.22%)
AEO : 19.52 (-2.20%)
Phreesia: Fiscal Q2 Earnings Snapshot

Phreesia: Fiscal Q2 Earnings Snapshot

PHR : 20.73 (-2.22%)
Phreesia: Fiscal Q1 Earnings Snapshot

Phreesia: Fiscal Q1 Earnings Snapshot

PHR : 20.73 (-2.22%)
Phreesia Sets Release Date for Fiscal First Quarter 2024 Results

Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2024 financial results after the close of market trading on Wednesday, May 31, 2023. Phreesia will...

PHR : 20.73 (-2.22%)
Unlimited Systems Partners with Phreesia, Improving Efficiency and Offering an Integrated Patient-Driven Intake Experience for Oncology Groups

Unlimited Systems, a leading revenue cycle application provider for specialty healthcare, and Phreesia, a leader in patient intake, outreach and activation, are partnering to offer a new integration that...

PHR : 20.73 (-2.22%)
Phreesia: Fiscal Q4 Earnings Snapshot

Phreesia: Fiscal Q4 Earnings Snapshot

PHR : 20.73 (-2.22%)
Phreesia Announces Chief Financial Officer Transition

Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, today announced the appointment of Balaji Gandhi as Phreesia’s Chief Financial Officer. Gandhi will succeed Randy Rasmussen,...

PHR : 20.73 (-2.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based...

See More

Key Turning Points

3rd Resistance Point 23.01
2nd Resistance Point 22.51
1st Resistance Point 21.85
Last Price 20.73
1st Support Level 20.69
2nd Support Level 20.19
3rd Support Level 19.53

See More

52-Week High 34.98
Fibonacci 61.8% 26.22
Fibonacci 50% 23.51
Fibonacci 38.2% 20.81
Last Price 20.73
52-Week Low 12.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar